These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6751064

  • 1. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    Singh BN, Chew CY, Josephson MA, Packer M.
    Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acute haemodynamic effects of cromakalim in patients with angina pectoris.
    Thomas P, Dixon MS, Winterton SJ, Sheridan DJ.
    Br J Clin Pharmacol; 1990 Mar; 29(3):325-31. PubMed ID: 2310656
    [Abstract] [Full Text] [Related]

  • 7. Antianginal drugs for stable angina pectoris.
    Aronow WS.
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract] [Full Text] [Related]

  • 8. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
    Maseri A, Crea F, Lanza GA.
    Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047
    [No Abstract] [Full Text] [Related]

  • 9. Cardiocirculatory and antianginal actions of nitroglycerin ointment. Evaluation by cardiac catheterization, forearm plethysmography and treadmill stress testing.
    Awan NA, Miller RR, Maxwell KS, Mason DT.
    Chest; 1978 Jan; 73(1):14-8. PubMed ID: 413695
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of intravenously administered verapamil on hemodynamic variables and ventricular function in acute myocardial infarction.
    Singh BN, Chew CY, Hecht H, Collett J, Ormiston J.
    Clin Invest Med; 1980 Jan; 3(1-2):73-80. PubMed ID: 7471543
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD, Bogatyrev IV, Uchaĭkina LV, Syrkin AL.
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [Abstract] [Full Text] [Related]

  • 16. Antianginal drugs.
    Kaverina NV, Chumburidze VB.
    Pharmacol Ther; 1979 Oct; 4(1):109-53. PubMed ID: 88742
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M, Matsunami T, Kodama Y, Sobue T, Nishinaka Y, Iwase M, Miyahara T, Koide M, Saito H, Shibata S.
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [Abstract] [Full Text] [Related]

  • 19. A kinetodardiographic approach to the evaluation of antianginal drugs.
    Slany J, Mösslacher H, Kronik G.
    Bibl Cardiol; 1976 Mar; (35):191-6. PubMed ID: 825098
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.